Tetanism: pathobiological aspects of the action of tetanal toxin in the nervous system and skeletal muscle.
D000109:Acetylcholine / Q000378:metabolism; D000110:Acetylcholinesterase / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002490:Central Nervous System / Q000473:pathology / Q000503:physiopathology; D003402:Creatine Kinase / Q000378:metabolism; D006801:Humans; D051379:Mice; D009132:Muscles / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009420:Nervous System / Q000187:drug effects*; D009469:Neuromuscular Junction / Q000503:physiopathology; D011955:Receptors, Drug; D013742:Tetanus / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D013743:Tetanus Antitoxin / Q000494:pharmacology; D013744:Tetanus Toxin / Q000302:isolation & purification / Q000494:pharmacology*
D011955:Receptors, Drug; D013743:Tetanus Antitoxin; D013744:Tetanus Toxin; D000255:Adenosine Triphosphate; D003402:Creatine Kinase; D000110:Acetylcholinesterase; D000251:Adenosine Triphosphatases; D000109:Acetylcholine